CHS Symptoms: Recognize Cannabinoid Hyperemesis

Cannabinoid Hyperemesis Syndrome (CHS) is a rare but increasingly recognized condition linked to long-term, heavy cannabis use, characterized by recurrent episodes of severe nausea, vomiting, and abdominal pain.

Previously underdiagnosed, CHS has become a leading cause of cannabis-related emergency room visits, particularly as cannabis legalization expands access. Symptoms often cycle through distinct phases and are uniquely relieved by hot showers or baths, a hallmark feature.

What Is Cannabinoid Hyperemesis Syndrome (CHS)?

**CHS** develops in individuals with chronic, frequent cannabis use—typically daily or multiple times per day for years—triggering cyclical gastrointestinal distress. Unlike typical nausea from overindulgence, CHS episodes are intense, unpredictable, and resistant to standard anti-nausea treatments.

The syndrome was first described in 2004 among long-term marijuana users presenting with intractable vomiting. Today, with rising cannabis potency and prevalence, CHS cases have surged, affecting even medical users. Risk factors include starting cannabis before age 16, co-occurring substance use disorders, and cigarette smoking.

Symptoms of Cannabinoid Hyperemesis Syndrome

CHS manifests through escalating gastrointestinal symptoms that disrupt daily life. Common signs include:

• Intense, persistent

  nausea

  , often starting in the morning.
• Frequent

  vomiting

  and retching, sometimes 20+ times per episode.
• Stabbing

  abdominal pain

  or cramping.
• **Loss of appetite** and unintended

  weight loss

  .
• **Fear of vomiting** (emetophobia).
• Compulsive

  hot bathing or showering

  for symptom relief.

Episodes can last hours to days, leading to dehydration and exhaustion. The hot water compulsion stems from activation of TRPV1 receptors, temporarily countering cannabinoid-induced dysregulation.

CHS Phases and Timeline

CHS progresses through three phases, often after years of heavy use (average 10-15 years).

The prodromal phase is insidious, as users may consume more cannabis believing it soothes stomachs. Hyperemetic attacks strike abruptly, often within 24 hours of last use. Recovery requires complete cessation; symptoms recur rapidly upon re-exposure.

CHS Causes and Risk Factors

The exact mechanism remains unclear, but hypotheses include:

• Chronic overstimulation of

  endocannabinoid receptors

  (CB1), dysregulating gut-brain nausea pathways.
• Disruption of

  TRPV1 receptors

  , explaining hot water relief via capsaicin-like effects.
• THC accumulation in fat tissues, causing prolonged exposure even after stopping.
• HPA axis dysregulation from stress response alteration.

Risk escalates with higher THC potency in modern cannabis products. Genetic factors and co-morbidities like CVS may predispose individuals.

How Is CHS Diagnosed?

Diagnosis relies on clinical history per Rome IV criteria:

• Stereotypical episodic vomiting (≥3 months, onset ≥6 months prior).
• Prolonged, heavy cannabis use (>1 year, >4 days/week).
• Resolution with sustained abstinence (confirmed negative urine THC).
• Compulsive hot bathing.

Ruling out mimics like CVS, GERD, pancreatitis, or appendicitis requires labs, imaging, and endoscopy. A trial cannabis cessation (4-6 weeks) confirms diagnosis if symptoms abate.

CHS Treatment and Management

The sole cure is

complete cannabis abstinence

• IV fluids for hydration and electrolytes.
• Anti-emetics (e.g., ondansetron; avoid cannabinoids).
• Benzodiazepines or haloperidol for refractory cases.
• Capsaicin cream topically for TRPV1 stimulation.

Home relief: Hot showers, small bland meals, ginger. Behavioral therapy aids long-term cessation.

CHS Complications

Untreated episodes risk:

• Dehydration/electrolyte imbalance** (hypokalemia, hypophosphatemia).
• **Aspiration pneumonia**.
• **Esophageal tears/rupture** (Mallory-Weiss).
• **Renal failure** from volume depletion.
• **Pneumomediastinum**.

Repeated ER visits strain healthcare; early recognition prevents escalation.

Prevention and Living with CHS

Prevent by moderating use, especially high-THC products. Medical users should monitor for prodromal signs. Support groups and counseling address addiction. Public education is key amid legalization.

Frequently Asked Questions (FAQs)

Q: Who gets CHS?

A: Primarily long-term daily cannabis users (years of heavy exposure); higher risk if starting young or with other substance use.

Q: Why do hot showers help CHS?

A: Heat activates TRPV1 receptors, countering cannabinoid-induced nausea dysregulation.

Q: How long until CHS symptoms stop?

A: 1-4 weeks for acute relief, full recovery 1-3 months with abstinence; THC lingers in fat.

Q: Is CHS the same as cyclic vomiting syndrome (CVS)?

A: Similar presentation, but CVS lacks cannabis link; CHS is CVS triggered by chronic use.

Q: Can CHS be treated without quitting cannabis?

A: No; partial reduction often fails. Abstinence is essential for resolution.

Q: Is CHS increasing?

A: Yes, paralleling cannabis legalization and potent products; now top marijuana-related ER cause.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb